Literature DB >> 3295042

Bacterial invasion of fibroblasts induces interferon production.

C B Hess, D W Niesel, Y J Cho, G R Klimpel.   

Abstract

Although bacteria and/or bacterial products have been shown to induce interferon (IFN) production in cells of the immune system, the ability of non-lymphoid cells to produce IFN in response to bacterial products and/or bacterial invasion is currently unknown. In this study we examined murine and human fibroblasts for their ability to produce IFN in response to challenge with the invasive bacteria Shigella flexneri and enteroinvasive Escherichia coli. Both human and murine primary cell cultures produced high levels (500 to 1000 U/ml) of IFN-beta within 12 hr after Shigella invasion. The production of IFN appeared to be dependent upon bacterial invasion because no IFN was produced by cells pretreated with a non-invasive isogenic variant of S. flexneri. Furthermore, UV treated invasive S. flexneri, which lose the ability to invade cells, failed to induce IFN production in fibroblasts after bacterial challenge. In contrast to primary cells, most human and murine continuous cell lines did not produce IFN in response to Shigella invasion. The above results demonstrate that bacterial invasion of primary cultures of fibroblasts can induce IFN production. Taken together with previous findings, these results suggest that IFN may play an important front line host defense against invasive bacterial infections.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3295042

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis.

Authors:  B Henderson; S Poole; M Wilson
Journal:  Microbiol Rev       Date:  1996-06

Review 2.  Bacterial perturbation of cytokine networks.

Authors:  M Wilson; R Seymour; B Henderson
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Interferon production by Shigella flexneri-infected fibroblasts depends upon intracellular bacterial metabolism.

Authors:  C B Hess; D W Niesel; J Holmgren; G Jonson; G R Klimpel
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

4.  Lipoprotein release by bacteria: potential factor in bacterial pathogenesis.

Authors:  H Zhang; D W Niesel; J W Peterson; G R Klimpel
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

5.  Tumor necrosis factor alpha binding to bacteria: evidence for a high-affinity receptor and alteration of bacterial virulence properties.

Authors:  G Luo; D W Niesel; R A Shaban; E A Grimm; G R Klimpel
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

6.  Natural killer cell activation and interferon production by peripheral blood lymphocytes after exposure to bacteria.

Authors:  G R Klimpel; D W Niesel; M Asuncion; K D Klimpel
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

7.  TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA.

Authors:  Marie Charrel-Dennis; Eicke Latz; Kristen A Halmen; Patrick Trieu-Cuot; Katherine A Fitzgerald; Dennis L Kasper; Douglas T Golenbock
Journal:  Cell Host Microbe       Date:  2008-12-11       Impact factor: 21.023

8.  Interactions of the invasive pathogens Salmonella typhimurium, Listeria monocytogenes, and Shigella flexneri with M cells and murine Peyer's patches.

Authors:  V B Jensen; J T Harty; B D Jones
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

Review 9.  Plasmacytoid Dendritic Cells: Neglected Regulators of the Immune Response to Staphylococcus aureus.

Authors:  Isabelle Bekeredjian-Ding; Johann Greil; Sandra Ammann; Marijo Parcina
Journal:  Front Immunol       Date:  2014-05-23       Impact factor: 7.561

10.  Induction of type I and type III interferons by Borrelia burgdorferi correlates with pathogenesis and requires linear plasmid 36.

Authors:  Michelle A Krupna-Gaylord; Dionysios Liveris; Andrea C Love; Gary P Wormser; Ira Schwartz; Mary M Petzke
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.